Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases

Alexander Schmitz, Ananthakrishnan Sankaranarayanan, Philippe Azam, Kristina Schmidt-Lassen, Daniel Homerick, Wolfram Hänsel and Heike Wulff
Molecular Pharmacology November 2005, 68 (5) 1254-1270; DOI: https://doi.org/10.1124/mol.105.015669
Alexander Schmitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ananthakrishnan Sankaranarayanan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Azam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristina Schmidt-Lassen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Homerick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfram Hänsel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heike Wulff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 68 no. 5 1254-1270
DOI 
https://doi.org/10.1124/mol.105.015669
PubMed 
16099841

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received June 10, 2005
  • Accepted August 10, 2005
  • Published online October 26, 2005.

Article Versions

  • Earlier version (August 11, 2005 - 08:35).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Alexander Schmitz,
  2. Ananthakrishnan Sankaranarayanan,
  3. Philippe Azam,
  4. Kristina Schmidt-Lassen,
  5. Daniel Homerick,
  6. Wolfram Hänsel and
  7. Heike Wulff
  1. Pharmaceutical Institute, University of Kiel, Kiel, Germany (A.Sc., K.S.-L., W.H.); and Department of Medical Pharmacology and Toxicology, University of California, Davis, Davis, California (A.Sa., P.A., D.H., H.W.)
  1. Address correspondence to:
    Heike Wulff, Department of Medical Pharmacology and Toxicology, Genome and Biomedical Sciences Facility, Room 3502, 451 East Health Sciences Drive, University of California, Davis, Davis, CA 95616. E-mail: hwulff{at}ucdavis.edu.
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2005 to August 2022

AbstractFullPdf
Aug 2005270168
Sep 2005190170
Oct 20055112127
Nov 20055810978
Dec 2005266638
Jan 2006464865
Feb 2006252733
Mar 2006342624
Apr 2006213741
May 2006243124
Jun 2006232735
Jul 2006272924
Aug 2006353345
Sep 2006202922
Oct 2006303550
Nov 2006276955
Dec 2006125443
Jan 2007285356
Feb 2007167891
Mar 2007235952
Apr 2007176130
May 2007116346
Jun 2007203950
Jul 2007313946
Aug 2007175339
Sep 2007165038
Oct 2007296454
Nov 2007245139
Dec 2007114333
Jan 2008154036
Feb 2008293528
Mar 2008273836
Apr 2008293737
May 2008315341
Jun 2008315440
Jul 2008466845
Aug 2008424439
Sep 2008715043
Oct 2008537771
Nov 2008474437
Dec 2008343330
Jan 2009485241
Feb 2009273618
Mar 2009504233
Apr 2009424647
May 2009193326
Jun 2009362329
Jul 2009254133
Aug 2009282628
Sep 2009312229
Oct 2009584126
Nov 2009534531
Dec 2009403526
Jan 2010322828
Feb 2010372226
Mar 2010532242
Apr 2010473228
May 2010653921
Jun 2010441925
Jul 2010421422
Aug 2010432820
Sep 2010322318
Oct 2010353429
Nov 2010385035
Dec 2010372335
Jan 2011473236
Feb 2011203133
Mar 2011372637
Apr 2011271719
May 2011252530
Jun 2011242316
Jul 2011322234
Aug 2011412333
Sep 2011383243
Oct 2011253025
Nov 2011442326
Dec 2011311728
Jan 2012342740
Feb 2012523542
Mar 2012474932
Apr 2012552824
May 2012512439
Jun 2012333341
Jul 2012482227
Aug 2012572533
Sep 2012312727
Oct 2012694159
Nov 2012634437
Dec 2012514141
Jan 2013734043
Feb 2013452917
Mar 2013674434
Apr 2013682732
May 2013762026
Jun 2013563830
Jul 2013431316
Aug 2013392116
Sep 2013441622
Oct 2013762537
Nov 2013511420
Dec 2013591416
Jan 2014511517
Feb 2014672225
Mar 2014631920
Apr 2014652417
May 2014694638
Jun 2014523843
Jul 2014553634
Aug 201433129
Sep 2014442020
Oct 2014502622
Nov 2014353622
Dec 2014582424
Jan 2015433521
Feb 2015374136
Mar 2015563523
Apr 2015494026
May 2015433122
Jun 2015303213
Jul 2015524828
Aug 2015412012
Sep 20153722148
Oct 2015454621
Nov 2015332622
Dec 2015371715
Jan 2016482018
Feb 2016572323
Mar 2016552540
Apr 2016332629
May 2016353129
Jun 2016323018
Jul 2016403323
Aug 2016684126
Sep 2016443220
Oct 20161620417
Nov 2016177725
Dec 201616116
Jan 201788913
Feb 201798618
Mar 20171210521
Apr 20172112019
May 2017167026
Jun 2017187013
Jul 2017186830
Aug 2017146217
Sep 2017128224
Oct 201766919
Nov 2017147716
Dec 2017175216
Jan 2018196919
Feb 2018266827
Mar 2018267631
Apr 2018258012
May 201896935
Jun 201857325
Jul 201837334
Aug 201815419
Sep 201845926
Oct 201875430
Nov 201847926
Dec 2018652927
Jan 2019971314
Feb 2019591111
Mar 201980712
Apr 20195458
May 2019601314
Jun 201968711
Jul 20194853
Aug 20197043
Sep 20191241622
Oct 2019841018
Nov 201992810
Dec 20198158
Jan 20204374
Feb 20206421
Mar 202058109
Apr 20205673
May 20204597
Jun 20204620
Jul 2020641510
Aug 20204568
Sep 20204396
Oct 20206224
Nov 20204156
Dec 202035138
Jan 202148149
Feb 2021621913
Mar 2021612015
Apr 2021471310
May 202169129
Jun 20213471
Jul 202124911
Aug 202144125
Sep 202161156
Oct 20215095
Nov 20216467
Dec 20215023
Jan 20227187
Feb 20224484
Mar 202283118
Apr 202262105
May 20228375
Jun 20228196
Jul 20227045
Aug 20221021

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 68 (5)
Molecular Pharmacology
Vol. 68, Issue 5
1 Nov 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases

Alexander Schmitz, Ananthakrishnan Sankaranarayanan, Philippe Azam, Kristina Schmidt-Lassen, Daniel Homerick, Wolfram Hänsel and Heike Wulff
Molecular Pharmacology November 1, 2005, 68 (5) 1254-1270; DOI: https://doi.org/10.1124/mol.105.015669

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases

Alexander Schmitz, Ananthakrishnan Sankaranarayanan, Philippe Azam, Kristina Schmidt-Lassen, Daniel Homerick, Wolfram Hänsel and Heike Wulff
Molecular Pharmacology November 1, 2005, 68 (5) 1254-1270; DOI: https://doi.org/10.1124/mol.105.015669
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • α-Conotoxin Binding Site on the GABAB Receptor
  • Upacicalcet binds to the amino acid binding site of CaSR
  • Characterization of GRD and LCCH3 from Human Louse
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics